Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to evaluate the safety and immunogenicity of concomitant Prevenar and Meningitec compared to Prevenar alone and Meningitec alone when used as part of the routine vaccination series in healthy infants
Epistemonikos ID: 1fcb74dbcf7e88516cbb20380c09943651227689
First added on: May 04, 2024